Drug Trial Radar · NCT00604890
Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma
Last checked: Nov 19, 2026Latest source record: Feb 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
186
Actual
Start
Mar 2008
Primary completion
Jan 2010
Study completion Jan 2010
Sponsor
- Lead sponsor
- BPGbioIndustry
- Sponsor type
- Industry
- First posted
- Jan 30, 2008
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the safety and tolerability of pharmaceutical compound (API 31510) topical cream topically applied to superficial basal cell carcinomas to obtain preliminary efficacy data for the treatment of superficial basal cell carcinomas by API 31510 topical cream. The study population will include one hundred and sixty (160) otherwise healthy male or female adults with one or more histologically confirmed superficial basal cell carcinoma lesions. One target lesion with an area of less than one inch will be designated for study treatment.
Conditions
- Superficial Basal Cell Carcinoma
Interventions
API 31510 3% Topical CreamDrug
Topical treatment 3% active cream applied to the lesion
API 31510 1.5% Topical CreamDrug
Topical treatment 1.5% active cream applied to the lesion
PlaceboOther
Topical treatment placebo applied to the lesion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Complete ResponseTime frame: 10 weeks
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
Burke Pharmaceuticals
Hot Springs, Arkansas
Skin Surgery Medical Group, Inc.
San Diego, California
Colorado Medical Research Center
Denver, Colorado
Dermatology Associates and Research
Coral Gables, Florida
Gwinnett Clinical Research
Snellville, Georgia
Scott D. Glazer, M.D., S.C.
Buffalo Grove, Illinois
Christie Clinic
Champaign, Illinois
Long Island Skin Cancer and Dermatologic Surgery, PC
Smithtown, New York
Oregon Dermatology and Research Center
Portland, Oregon
Dermatology Clinical Research Center of San Antonio
San Antonio, Texas
Education & Research Foundation
Lynchburg, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.